By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Health Works CollectiveHealth Works CollectiveHealth Works Collective
  • Health
    • Mental Health
    Health
    Healthcare organizations are operating on slimmer profit margins than ever. One report in August showed that they are even lower than the beginning of the…
    Show More
    Top News
    magnesium water can be good for your health but you can't have too much
    Is Drinking Magnesium Water Good for Your Health?
    October 17, 2023
    common misconseptions about brain injuries
    4 Common Myths and Misunderstandings About Brain Injuries
    February 5, 2023
    get a career in medical device sales
    What Are the Benefits of Attending Medical Sales College?
    April 10, 2023
    Latest News
    How Probate Planning Shapes the Future of Your Estate and Family Care
    July 17, 2025
    Beyond Nutrition: Everyday Foods That Support Whole-Body Health
    June 15, 2025
    The Wide-Ranging Benefits of Magnesium Supplements
    June 11, 2025
    The Best Home Remedies for Migraines
    June 5, 2025
  • Policy and Law
    • Global Healthcare
    • Medical Ethics
    Policy and Law
    Get the latest updates about Insurance policies and Laws in the Healthcare industry for different geographical locations.
    Show More
    Top News
    Elective Coronary Stenting: A Case in Context
    August 3, 2011
    PSA screening: Does It or Doesn’t It?
    March 16, 2012
    Rick Perry Needs To Make Up His Mind
    September 19, 2011
    Latest News
    How IT and Marketing Teams Can Collaborate to Protect Patient Trust
    July 17, 2025
    How Health Choices and Legal Actions Intersect After an Injury
    July 17, 2025
    How communities and healthcare providers can address slip and fall injuries with legal awareness
    July 17, 2025
    Let Your Lawyer Handle the Work Before You Pay Medical Costs
    July 6, 2025
  • Medical Innovations
  • News
  • Wellness
  • Tech
Search
© 2023 HealthWorks Collective. All Rights Reserved.
Reading: New Software From iCAD Helps Doctors Diagnose Prostate Cancer
Share
Notification Show More
Font ResizerAa
Health Works CollectiveHealth Works Collective
Font ResizerAa
Search
Follow US
  • About
  • Contact
  • Privacy
© 2023 HealthWorks Collective. All Rights Reserved.
Health Works Collective > Diagnostics > New Software From iCAD Helps Doctors Diagnose Prostate Cancer
Diagnostics

New Software From iCAD Helps Doctors Diagnose Prostate Cancer

HerinaAyot
HerinaAyot
Share
4 Min Read
The Need-to-Know About Breast Cancer
SHARE

It’s the second most common form of cancer in men, yet diagnosing it still presents a challenge to physicians.

It’s the second most common form of cancer in men, yet diagnosing it still presents a challenge to physicians. Now, new software being used at Englewood Hospital and Medical Center should help detect prostate cancer earlier, eliminate unnecessary testing procedures and help form a treatment plan.

VividLook, a new program used with magnetic resonance imaging exams, makes test results much easier to read and enables physicians to pinpoint where a malignancy may be located in the prostate.

“This is another tool in the approach in the management of prostate cancer,” said Dr. Mark Shapiro, chief of radiology at Englewood. “It will potentially eliminate the need for biopsies in some men and help guide biopsies in others so we will have a lot less false-negative biopsy results.”

More Read

Mammography Scheduling Portal Helps Improve Screening Attendance in Denmark
X-Ray Dosimeter Improves Radiation Dose Management in Real-Time: Or, How a Little Badge Provides Real-Time Radiation Dose Data
Breast Cancer: The Mammography Controversy
Measuring Physician Quality – Bully or Just Plain Bull
When Culture Trumps Knowledge: Breaking Habits Takes More than New Research

Screening for prostate cancer begins with a digital rectal exam and a blood test that gauges the level of a protein, prostate specific antigen. Typically, a 4 or below is a normal PSA. Patients with higher levels may be urged to get a biopsy.

“But when we don’t have any images to look at, the biopsies are just random samples of different areas,” Shapiro said. “So it’s very easy to miss the cancer.”

In addition to not being very accurate, biopsies are invasive tests that may cause bleeding and infection. Even more distressing, many men undergo the procedure needlessly because most patients with an elevated PSA don’t have prostate cancer. Only 25 percent to 35 percent of the patients who undergo a biopsy with a PSA level between 4 and 9 have the disease, according to the National Cancer Institute.

VividLook should help eliminate the need for so many biopsies and should help physicians find tumors when they exist, doctors said. Before this software was created, doctors didn’t do MRIs on the prostate and had to perform biopsies almost blindly, sometimes taking as many as 12 tissue samples from all areas of the gland with each procedure. That’s because interpreting images of a gland that is filled with numerous veins and arteries and located deep within the pelvic cavity, behind the bladder, was nearly impossible.

“When you inject dye into the prostate, the whole thing kind of glows and it’s hard to distinguish what is suspicious,” said Liza Heapes, a spokeswoman for iCad,Inc., the New Hampshire-based company that makes VividLook.”VividLook uses different criteria and clinical data that show suspicious areas.”

Nearly 218,000 men nationwide are diagnosed with prostate cancer each year and more than 32,000 men die from the disease. About one in six men will be diagnosed with the disease in their lifetime, and it trails lung cancer as the second leading cause of death in men. But more than 2 million men are alive who were diagnosed with the disease at some point in their lives.

Armune Bioscience is an early-stage biopharmaceuticals company focused on the development and commercialization of high value, protein signature-based diagnostic tests for prostate, and other cancers, thereby allowing physicians and patients to make better treatment decisions. Envisioneering Medical Technologies develops a unique and proprietary scanning technology that uses ultrasound imaging to guide diagnostic biopsy sampling and to guide treatment delivery.

Source

 

TAGGED:diagnosticsprostate cancer
Share This Article
Facebook Copy Link Print
Share

Stay Connected

1.5kFollowersLike
4.5kFollowersFollow
2.8kFollowersPin
136kSubscribersSubscribe

Latest News

Grounded Healing: A Natural Ally for Sustainable Healthcare Systems
How IT and Marketing Teams Can Collaborate to Protect Patient Trust
Global Healthcare Policy & Law
July 17, 2025
paramedics in surgical gloves and masks
How Health Choices and Legal Actions Intersect After an Injury
Health care
July 16, 2025
a woman giving a key
How Probate Planning Shapes the Future of Your Estate and Family Care
Health
July 16, 2025
a woman with kinesio tapes on her back arm
How communities and healthcare providers can address slip and fall injuries with legal awareness
Health care
July 16, 2025

You Might also Like

Is Working in Telemedicine a Good Option for You?
DiagnosticseHealthRemote DiagnosticsWellness

Is Working in Telemedicine a Good Option for You?

May 6, 2016

Can a Blood Test Really Tell You When You’ll Die?

October 18, 2011
patient communities
BusinessDiagnosticseHealthHealth ReformHome HealthHospital AdministrationMedical DevicesMedical EducationMedical InnovationsMedical RecordsMobile HealthNewsPolicy & LawPublic HealthSocial MediaTechnologyWellness

Top Digital Health Innovations That Will Transform Healthcare

September 24, 2013

Drug Development Gets Even More Personal, Precise and Tailored

March 28, 2012
Subscribe
Subscribe to our newsletter to get our newest articles instantly!
Follow US
© 2008-2025 HealthWorks Collective. All Rights Reserved.
  • About
  • Contact
  • Privacy
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?